Quality Mailbag: We Moved Back

This company came back.

Dear Editor,

Our company manufactures medical devices and began manufacturing in China in 1995. The Chinese factory took our regulatory programs and FDA documentation and used them to distribute goods that we had rejected for import to the United States and other foreign markets to sell in the Chinese markets. They used our trademarks without telling us and kept the profits. We discovered that they used our registrations to import to their own trading company in the United States. Those shipments failed.

Our quality levels are designed to ensure consistent compliance with ISO, WHO, FDA, and ASTM requirements. The inability to know that only the goods that we approved to our quality requirements were in distribution was an unacceptable business risk. There were detailed contractual requirements for established quality parameters. Because payment is generally made at export, the ability to receive credit for defective goods was poor and rejection, once the goods had arrived, proved ineffective. Communication in China flows down but does not flow up because of the cultural desire to protect superiors. This has quality ramifications relative to corrective and preventive action, and the ISO requirement for continual improvement. It is cheaper to manufacture in China, however, one must also be prepared to qualify raw materials there. This can add cost or compromise quality. The Chinese quality levels for raw materials are not as good as in the West, so the logistics of planning for specialty goods must be considered. Once all of the parameters are set, it does not mean that the factory will not change them. We had several instances where we caught changes that were made without change control or documentation.

We decided to control our own processes and labels and returned manufacturing to the United States in 2000. Not because it was cheaper, but because it could be more efficiently controlled and quality levels could be maintained.

It would be nice to think you can shut the lid on Pandora’s box as you suggested. Pandora couldn’t and neither can those who manufacture in China. So much happens without direct oversight. Once it is not caught, it will continue until it is. Even then, compliance is achieved only until it’s thought there is no chance of being caught again.

Lillie C. Thomas, M.S.

Vice President of Quality Assurance and Regulatory Compliance

Custom Services International Inc.

Las Vegas

Did you enjoy this article? Click here to subscribe to Quality Magazine. 

You must login or register in order to post a comment.




Karen Spencer, Clinkenbeard's quality manager, discusses what makes the plant stand out, advice for other plants, and looks to the future.
More Podcasts

Quality Magazine


2015 May

The May 2015 edition of Quality Magazine includes articles on cloud technologies, depth gages, ISO 9001, digital inspection and cool new products.

Table Of Contents Subscribe

Topics to Talk About

What topics would you like to see Quality cover more?
View Results Poll Archive

Clear Seas Research

qcast_ClearSeas_logo.gifWith access to over one million professionals and more than 60 industry-specific publications,Clear Seas Research offers relevant insights from those who know your industry best. Let us customize a market research solution that exceeds your marketing goals.


Facebook2015_40 twitter_40px.png  youtube_40px.pnglinkedin_40px.png